Experimental autoimmune neuritis induces differential microglia activation in the rat spinal cord
Introduction
Experimental autoimmune neuritis (EAN) is an acute demyelinating inflammatory disease of the peripheral nervous system (PNS) mediated by autoantigen-specific T cells (Gold et al., 1999, Linington et al., 1984, Mäurer and Gold, 2002, Shin et al., 1989, Spies et al., 1995, Taylor and Pollard, 2003).
Histopathologically, EAN is characterized by perivascular inflammatory lesions and severe demyelination of tissues in the PNS. These changes are entirely restricted to the PNS and do not directly involve the central nervous system (CNS) (Izumo et al., 1985). Therefore, only few studies have been performed concerning the impact of EAN on the CNS (Gehrmann et al., 1992, Gehrmann et al., 1993).
In spinal cord, immune-like glial cells (astrocytes and microglia) are activated in response to a variety of peripheral stimuli, resulting from degeneration of central terminals of dying sensory neurons or through the release of substances by incoming sensory afferents or pain-responsive neurons in the dorsal horn (Watkins and Maier, 2002). It has become evident that microglial cells play a key role in regulating the communication among neuronal and other types of glial cells (Nakamura, 2002). Microglia, expressing numerous receptors for CNS signaling molecules, is very sensitive to changes in the CNS microenvironment and rapidly become activated in virtually all conditions that affect normal neuronal function (Piehl and Lidman, 2001).
This study was performed to examine the reactive spatial and temporal activation pattern of spinal cord microglia in rat EAN.
Section snippets
Animals
Male Lewis rats (8–10 weeks old; 170–200 g, Charles River, Sulzfeld, Germany) were kept under controlled conditions of light and temperature. Food and water were available ad libitum. All rats were cared for in accordance with the published International Health Guidelines under a protocol approved by the University of Tübingen Institutional Animal Care and Use Committee and the Administration District Official Committee.
Experimental approach
Rats were immunized by subcutaneous injection of 50 μg of synthetic
Clinical course of EAN
Rats developed first neurological signs of EAN (reduced tail tonicity, Fig. 1) at Day 9 after immunization. Disease severity was maximal at Days 12–13, with rats showing mild to moderate paralysis of the hind limbs or paraparesis (mean clinical score of 5). Rats recovered fast from disease, and, by Day 19, neurological signs were no longer observed. Clinical scores were concomitant with progression of inflammatory response in peripheral nerves, as demonstrated by immunohistochemistry (data not
Discussion
Our study demonstrates that the peripheral inflammatory processes in EAN are mirrored in a central microglial response predominantly located in the grey matter dorsal horn. Spinal cord microglial activation is accompanied by a short-termed but generalized proliferative response affecting the entire spinal cord area.
Pathological activation of microglia has been reported in a wide range of conditions, such as degenerative lesions, cerebral ischemia, Alzheimer's disease, prion diseases, multiple
Acknowledgements
This work has been supported by a grant of the Deutsche Forschungsgemeinschaft (DFG).
References (33)
- et al.
Cellular forms and functions of brain microglia
Brain Res. Bull.
(1994) - et al.
Expression of interleukin-16 by microglial cells in inflammatory, autoimmune, and degenerative lesions of the rat brain
J. Neuroimmunol.
(2004) - et al.
ATP- and adenosine-mediated signaling in the central nervous system: chronic pain and microglia: involvement of the ATP receptor P2X4
J. Pharmacol. Sci.
(2004) - et al.
Two temporal stages of oligodendroglial response to excitotoxic lesion in the gray matter of the adult rat brain
Exp. Neurol.
(2001) - et al.
Identification of a neural stem cell in the adult mammalian central nervous system
Cell
(1999) - et al.
AIF-1 expression defines a proliferating and alert microglial/macrophage phenotype following spinal cord injury in rats
J. Neuroimmunol.
(2001) - et al.
Induction of experimental allergic neuritis with synthetic peptides from myelin P2 protein
Neurosci. Lett.
(1989) - et al.
Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease
Exp. Neurol.
(1999) - et al.
Synergy between antibody and P2-reactive T cells in experimental allergic neuritis
J. Neuroimmunol.
(1995) - et al.
Proliferation of parenchymal neural progenitors in response to injury in the adult rat spinal cord
Exp. Neurol.
(2001)
Immune function of microglia
Glia
Increased morphological diversity of microglia in the activated hypothalamic supraoptic nucleus
J. Neurosci.
Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1
Immunology
Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo
J. Neurochem.
Spinal cord microglia in experimental allergic neuritis. Evidence for fast and remote activation
Lab. Invest.
Microglial involvement in experimental autoimmune inflammation of the central and peripheral nervous system
Glia
Cited by (23)
Role of AIF-1 in the regulation of inflammatory activation and diverse disease processes
2013, Cellular ImmunologyCitation Excerpt :AIF-1 is also involved in autoimmune lesions of the nervous system such as experimental autoimmune encephalomyelitis (EAE), neuritis (EAN), and uveitis (EAU) [36,37]. In the diseased brain, AIF-1 positive microglial cells are not only found in the direct vicinity of the infiltrate, but also in the parenchyma [38]. In Lewis rats induced EAN by immunizing with bovine PNS myelin and complete Freund’s adjuvant, the expression of AIF-1 in spleen and in sciatic nerves peaks at the preclinical stage (day 7 post immunization (p.i.)) and at the height (day 15 p.i.) of clinical EAN detected by immune-histochemistry and radio-immunoassay.
When does acute pain become chronic?
2010, British Journal of AnaesthesiaCitation Excerpt :Hence, persistent glial cell activity producing these pro-inflammatory mediators plays a role in the development of a neuropathic pain state.78 79 Post-traumatic models, inflammatory models, central demyelinating disorders, and diabetes mellitus have all demonstrated a role for glial cell activation.78 80–86 Activation of microglia can be followed by increased expression of p38 mitogen-activated protein kinase (MAPK), which participates in a signalling cascade controlling cellular responses to cytokines and stress and is amplified across many painful conditions.87 88
Glia activation induced by peripheral administration of aluminum oxide nanoparticles in rat brains
2009, Nanomedicine: Nanotechnology, Biology, and MedicineCitation Excerpt :Upregulation of CD68 indicates that cells are phagocytically active, because they accumulate lysosomal vacuoles. ED1 staining has been widely applied to show microglia activation.23,24 Following 30 days' exposure no significant changes of glia activation were observed, but abundant reactive microglia and astrocytes were observed in the brains of NSAO-treated rats after 60 days of exposure.
Gabapentin reverses microglial activation in the spinal cord of streptozotocin-induced diabetic rats
2009, European Journal of PainCitation Excerpt :Microglia and astrocyte activation in the spinal cord is observed following PNS or CNS injury (Scholz and Woolf, 2007; Watkins and Maier, 2003). Glial activation is also shown in inflammatory models (Qin et al., 2006; Raghavendra et al., 2004; Sweitzer et al., 1999) as well as in demyelinating disorders such as experimental autoimmune neuritis (EAN) (Beiter et al., 2005; Luongo et al., 2008), viral diseases like Borna Disease Virus (Stahl et al., 2006) and following intrathecal HIV-1 envelope glycoprotein injection (Milligan et al., 2001). Relevant to this study, recent reports demonstrate spinal microglial activation in STZ-diabetic rats (Daulhac et al., 2006; Tsuda et al., 2008) and the analgesic effect of inhibitors of phosphorylation of the Mitogen Activated Protein Kinases (MAPKs) Extracellular Signal-regulated Protein Kinase (ERK) (Tsuda et al., 2008) and p38 (Daulhac et al., 2006; Sweitzer et al., 2004), a marker for activated microglia which is essential for cytokine synthesis and release by microglia.
Spinal changes associated with mechanical hypersensitivity in a model of Guillain-Barré syndrome
2008, Neuroscience LettersMechanical allodynia and spinal up-regulation of P2X<inf>4</inf> receptor in experimental autoimmune neuritis rats
2008, NeuroscienceCitation Excerpt :Recently, spinal glial (microglia and astrocytes) activation has been proven to be essential for the development of neuropathic pain. In EAN, spinal microglia activation was observed early, more pronounced in gray than in white matter (Beiter et al., 2005; Gehrmann et al., 1992, 1993; Izumo et al., 1985). Similarly to microglia, spinal astrocyte activation was observed early in EAN and lasted until the late stage.